Barclays
GRDN

Barclays’s Guardian Pharmacy Services GRDN Stock Holding History

Barclays’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182K Sell
4,834
-30,351
-86% -$992K ﹤0.01% 3746
2025
Q4 		$1.06M Buy
35,185
+7,212
+26% +$204K ﹤0.01% 3392
2025
Q3 		$734K Buy
27,973
+2,075
+8% +$49.5K ﹤0.01% 3565
2025
Q2 		$552K Buy
25,898
+16,964
+190% +$383K ﹤0.01% 3707
2025
Q1 		$190K Sell
8,934
-4,275
-32% -$87.7K ﹤0.01% 4070
2024
Q4 		$268K Sell
13,209
-5,291
-29% -$109K ﹤0.01% 4168
2024
Q3 		$311K Buy
+18,500
New +$312K ﹤0.01% 4062

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Barclays's GRDN Position: Q1 2026 in Review

Barclays reduced its Guardian Pharmacy Services (GRDN) stake by 86% in Q1 2026, selling an estimated $992K and leaving 4,834 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3746.

Barclays first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.06M in Q4 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Barclays held 4,834 shares of Guardian Pharmacy Services worth $182K as of Q1 2026.
  • Barclays sold 30,351 Guardian Pharmacy Services shares in Q1 2026, an estimated $992K.
  • Guardian Pharmacy Services made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3746 holding.
  • Barclays first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • Barclays's Guardian Pharmacy Services position peaked at $1.06M in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.